ViscumTT treatment, a whole mistletoe extract, significantly reduced tumor growth in ES cells in vivo through the JAK/STAT3 pathway and its downstream targets, including BIRC5 and Myc (Twardziok et al., 2016; Kleinsimon et al., 2018). The gene discussed is STAT3; the disease is neoplasm.